Hyogo, Japan

Junichi Sakamoto

This inventor holds 5 USPTO granted patents. Top assignee: Sumitomo Seika Chemicals Co., Ltd.. Active years: 1997-1999.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Junichi Sakamoto. Retrieved from https://idiyas.com/inventor/junichi-sakamoto-ps0ylyz8

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.4

ph-index = 2

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 1997-1999

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Junichi Sakamoto: Innovator in Pharmaceutical Preparations

Introduction

Junichi Sakamoto is a notable inventor based in Hyogo-ken, Japan. He has made significant contributions to the field of pharmaceuticals, holding a total of 5 patents. His work focuses on innovative processes that enhance the preparation of pharmaceutical compounds.

Latest Patents

One of his latest patents is titled "Process for preparation of 3-piperazinylbenzisothiazoles." This patent discloses a method for preparing 3-piperazinylbenzisothiazoles by reacting specific 3-halo-1,2-benzisothiazole or 2-cyanobenzenesulfenyl halide in the presence of an alkylene glycol derivative. The process is noted for being industrially effective, easy, and economical, providing useful intermediates for the production of pharmaceutical preparations.

Career Highlights

Junichi Sakamoto is associated with Sumitomo Seika Chemicals Co., Ltd., where he applies his expertise in chemical processes. His innovative approaches have contributed to advancements in pharmaceutical manufacturing.

Collaborations

He has collaborated with notable coworkers such as Hiroshi Goda and Shigeki Sakaue, further enhancing the impact of his work in the industry.

Conclusion

Junichi Sakamoto's contributions to pharmaceutical innovations through his patents and collaborations highlight his role as a key inventor in the field. His work continues to influence the development of effective pharmaceutical preparations.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…